RT Dissertation/Thesis
T1 Risk assessment in contemporary outpatients with non-valvular atrial fibrillation recently on vitamin K antagonists
A1 Abumuaileq, Rami Riziq Yousef
A2 Universidade de Santiago de Compostela. Facultade de Medicina e Odontoloxía. Departamento de Medicina, 
K1 atrial fibrillation
K1 risk assessment
K1 anticoagulation control
K1 thromboembolic events
AB Atrial Fibrillation increases the risk of embolic stroke by five fold. Vitamin Kantagonists (VKAs) are still the most used oral anticoagulants in patients with nonvalvularatrial fibrillation (NVAF) and are highly effective for the prevention ofthromboembolic (TE) complications in these patients. However, achieving the bestbenefit and safety from VKAs in the clinical practice remains a major challenge mainlybecause of their unpredictable anticoagulant response. In this thesis, we aimed toevaluate the quality of oral anticoagulation in a real world cohort of patients withNVAF recently on VKAs and to assess the risk of TE and major bleeding complicationsin a contemporary cohort of outpatients with NVAF anticoagulated with VKAs.Furthermore, in this thesis we also aimed to assess the usefulness and reliability ofdifferent contemporary risk estimation scales in atrial fibrillation.
YR 2016
FD 2016-06-27
LK http://hdl.handle.net/10347/14808
UL http://hdl.handle.net/10347/14808
LA eng
DS Minerva
RD 25 abr 2026